Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Clinical Cardiology
|
January 11, 2016
Ticagrelor in Triple Antithrombotic Therapy: Predictors of Ischemic and Bleeding Complications
Angel Fu, Kuljit Singh, Joseph Abunassar, et al.
Circulation. Cardiovascular Interventions
|
April 18, 2013
Response to letter regarding article, "Bivalirudin for primary percutaneous coronary interventions: outcome assessment in the Ottawa STEMI registry"
Benjamin Hibbert, Andrea MacDougall, Melissa Blondeau, et al.
Journal of the American Heart Association
|
June 14, 2022
Sex-Specific Differences in Clinical Outcomes After Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial
Mina Madan, J Dawn Abbott, Ryan Lennon, et al.
Plos One
|
March 22, 2014
A comparative pharmacodynamic study of ticagrelor versus clopidogrel and ticagrelor in patients undergoing primary percutaneous coronary intervention: the CAPITAL RELOAD study
Benjamin Hibbert, Ronnen Maze, Ali Pourdjabbar, et al.
The Canadian Journal of Cardiology
|
May 20, 2026
A Woman's Heart: The Microvascular Disease Dilemma
Laurie-Anne Boivin-Proulx, Derek Y F So, Heather Tulloch, et al.
Circulation. Population Health and Outcomes
|
February 16, 2026
Sex Differences in Psychological Distress of Patients With Spontaneous Coronary Artery Dissection (SCAD): The MINDSET Study
Lisa-Marie Maukel, Thais Coutinho, Sharon L Mulvagh, et al.
Lancet (London, England)
|
April 3, 2012
Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial
Jason D Roberts, George A Wells, Michel R Le May, et al.
International Journal of Cardiology
|
July 8, 2015
A pharmacodynamic comparison of a personalized strategy for anti-platelet therapy versus ticagrelor in achieving a therapeutic window
Nikita Malhotra, Joseph Abunassar, George A Wells, et al.
Thrombosis and Haemostasis
|
October 21, 2016
A randomised study for optimising crossover from ticagrelor to clopidogrel in patients with acute coronary syndrome. The CAPITAL OPTI-CROSS Study
Ali Pourdjabbar, Benjamin Hibbert, Aun-Yeong Chong, et al.
The American Journal of Cardiology
|
November 19, 2021
Outcomes in Patients Stratified by PRECISE-DAPT Versus DAPT Scores After Percutaneous Coronary Interventions
Rene Boudreau, Angel Y N Fu, Quinton S Barry, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Clinical Cardiology
|
January 11, 2016
Ticagrelor in Triple Antithrombotic Therapy: Predictors of Ischemic and Bleeding Complications
Angel Fu, Kuljit Singh, Joseph Abunassar, et al.
Circulation. Cardiovascular Interventions
|
April 18, 2013
Response to letter regarding article, "Bivalirudin for primary percutaneous coronary interventions: outcome assessment in the Ottawa STEMI registry"
Benjamin Hibbert, Andrea MacDougall, Melissa Blondeau, et al.
Journal of the American Heart Association
|
June 14, 2022
Sex-Specific Differences in Clinical Outcomes After Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial
Mina Madan, J Dawn Abbott, Ryan Lennon, et al.
Plos One
|
March 22, 2014
A comparative pharmacodynamic study of ticagrelor versus clopidogrel and ticagrelor in patients undergoing primary percutaneous coronary intervention: the CAPITAL RELOAD study
Benjamin Hibbert, Ronnen Maze, Ali Pourdjabbar, et al.
The Canadian Journal of Cardiology
|
May 20, 2026
A Woman's Heart: The Microvascular Disease Dilemma
Laurie-Anne Boivin-Proulx, Derek Y F So, Heather Tulloch, et al.
Circulation. Population Health and Outcomes
|
February 16, 2026
Sex Differences in Psychological Distress of Patients With Spontaneous Coronary Artery Dissection (SCAD): The MINDSET Study
Lisa-Marie Maukel, Thais Coutinho, Sharon L Mulvagh, et al.
Lancet (London, England)
|
April 3, 2012
Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial
Jason D Roberts, George A Wells, Michel R Le May, et al.
International Journal of Cardiology
|
July 8, 2015
A pharmacodynamic comparison of a personalized strategy for anti-platelet therapy versus ticagrelor in achieving a therapeutic window
Nikita Malhotra, Joseph Abunassar, George A Wells, et al.
Thrombosis and Haemostasis
|
October 21, 2016
A randomised study for optimising crossover from ticagrelor to clopidogrel in patients with acute coronary syndrome. The CAPITAL OPTI-CROSS Study
Ali Pourdjabbar, Benjamin Hibbert, Aun-Yeong Chong, et al.
The American Journal of Cardiology
|
November 19, 2021
Outcomes in Patients Stratified by PRECISE-DAPT Versus DAPT Scores After Percutaneous Coronary Interventions
Rene Boudreau, Angel Y N Fu, Quinton S Barry, et al.
Page
of 5